Stock listing
DNTH Stock Price, News, Filings & Events — Dianthus Therapeutics, Inc.
Selected listing: DNTH · NASDAQ · USD · US
This page tracks Dianthus Therapeutics, Inc.'s DNTH:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DNTH:NASDAQ. DNTH:NASDAQ is the stock-level entry point for investors researching Dianthus Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Dianthus Therapeutics, Inc. is a public company traded under the ticker DNTH in the American market. The company has a market capitalization of approximately $5.68 billion. Dianthus focuses on developing innovative therapies in the biotechnology sector.
- Ticker
- DNTH:NASDAQ
- Asset type
- Stock
- Market cap
- $5.92B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Dianthus Therapeutics, Inc. DNTH:NASDAQ stock context
This page tracks Dianthus Therapeutics, Inc.'s DNTH:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DNTH:NASDAQ. DNTH:NASDAQ is the stock-level entry point for investors researching Dianthus Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Dianthus Therapeutics, Inc. is a public company traded under the ticker DNTH in the American market. The company has a market capitalization of approximately $5.68 billion. Dianthus focuses on developing innovative therapies in the biotechnology sector.
Latest news from Dianthus Therapeutics, Inc.
Dianthus Therapeutics to Participate in Three Investor Conferences During September
September 1, 2026
Dianthus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
August 3, 2026
Dianthus Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(C)(4)
July 2, 2026
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
June 3, 2026
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 2, 2026
Research Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for DNTH:NASDAQ.
Dianthus Therapeutics, Inc. company profile
View the public company page for Dianthus Therapeutics, Inc. on 6ix.
Dianthus Therapeutics, Inc. news
Read company news and market updates connected to Dianthus Therapeutics, Inc..
Dianthus Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Dianthus Therapeutics, Inc..
Alternate listings
87E:GETTEX
DE · EUR
Alternate listing for Dianthus Therapeutics, Inc.; the primary context on this page is DNTH:NASDAQ.
87E:TRADEGATE
DE · EUR
Alternate listing for Dianthus Therapeutics, Inc.; the primary context on this page is DNTH:NASDAQ.
A3ERZ4:LSX
DE · EUR
Alternate listing for Dianthus Therapeutics, Inc.; the primary context on this page is DNTH:NASDAQ.
A3ERZ4:LS
DE · EUR
Alternate listing for Dianthus Therapeutics, Inc.; the primary context on this page is DNTH:NASDAQ.
DNTH:BOATS
US · USD
Alternate listing for Dianthus Therapeutics, Inc.; the primary context on this page is DNTH:NASDAQ.
87E:DUS
DE · EUR
Alternate listing for Dianthus Therapeutics, Inc.; the primary context on this page is DNTH:NASDAQ.
87E:FWB
DE · EUR
Alternate listing for Dianthus Therapeutics, Inc.; the primary context on this page is DNTH:NASDAQ.
87E:MUN
DE · EUR
Alternate listing for Dianthus Therapeutics, Inc.; the primary context on this page is DNTH:NASDAQ.
87E:SWB
DE · EUR
Alternate listing for Dianthus Therapeutics, Inc.; the primary context on this page is DNTH:NASDAQ.